Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
contrast agent |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
V08CA10
|
| gptkbp:brand |
gptkb:Primovist
gptkb:Eovist |
| gptkbp:CASNumber |
135326-22-6
|
| gptkbp:chemicalFormula |
C23H28GdN3Na2O11
|
| gptkbp:containsElement |
gptkb:gadolinium
|
| gptkbp:eliminationHalfLife |
0.75 hours
|
| gptkbp:excretion |
renal
biliary |
| https://www.w3.org/2000/01/rdf-schema#label |
gadoxetate disodium
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
headache allergic reaction |
| gptkbp:usedFor |
magnetic resonance imaging
liver imaging |
| gptkbp:bfsParent |
gptkb:Primovist
|
| gptkbp:bfsLayer |
7
|